Medications, AstraZeneca Bets on Clinical Research Made in Italy
14 Articles
14 Articles
The company invests 66 million, with the co-financing of Mimit and Fondazione Tech and Biomedical: involved 200 health centers and structures to test the new therapies with an impact of 180 million
AstraZeneca invests 66.2 million in three years in Italian clinical research: 200 centers involved and 71 new studies, with the co-financing of the Mimit. L'articolo Clinical research, AstraZeneca invests 66.2 million euros out of 200 centers in Italy comes from Fortune Italia.
AstraZeneca announces an investment programme of 66.2 million euros in Italy over the next 3 years, in an international context characterized by a growing competition to attract investments, skills and research activities. The initiative is also implemented thanks to the co-financing of 20 million euros of the Research and Development Fund [...]
AstraZeneca announces an investment programme of 66.2 million euros in Italy over the next 3 years. The initiative, also implemented thanks to the co-financing of 20 million euros of the Fund for Research and Development [...] L'articolo AstraZeneca, in Italia program for investments in research from 66.2 million euros in 3 years comes from Calabria News.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium






